Citius Pharmaceuticals, Inc.
|Number of Estimates|
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
Market Cap: 10.2 Million
Primary Exchange: NASDAQ
Shares Outstanding: 45.2 Million
Sector: Health Technology
Industry: Pharmaceuticals: Major
Longest drawdown: 46 trading days
From: 2018-11-19 To: 2019-01-29
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|